Keros Therapeutics shares owned by Birchview Capital
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Birchview Capital
from 13F filings
Historical chart of Birchview Capital investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Birchview Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $407k | 7.0k | 58.07 |
| 2024-06-30 | $320k | 7.0k | 45.70 |
| 2024-03-31 | $463k | 7.0k | 66.20 |
| 2023-12-31 | $278k | 7.0k | 39.76 |
| 2023-09-30 | $223k | 7.0k | 31.88 |
| 2023-06-30 | $281k | 7.0k | 40.18 |
| 2023-03-31 | $299k | 7.0k | 42.71 |
| 2022-12-31 | $336k | 7.0k | 48.00 |